Invasive human pancreatic carcinoma cells adhere to endothelial tri-cellular corners and increase endothelial permeability

Cancer Science

Volumn 96, Issue 11, 2005, Pages 766-773

  Nakai, Kei ^a   Tanaka, Toshiyuki ^a   Murai, Toshiyuki ^a   Ohguro, Nobuyuki ^a   Tano, Yasuo ^a   Miyasaka, Masayuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA1 INTEGRIN; CADHERIN; CD31 ANTIGEN; CD9 ANTIGEN; CYTOCHALASIN B; HERMES ANTIGEN; LIPOXYGENASE; METALLOPROTEINASE; NEUTRALIZING ANTIBODY; PARAFORMALDEHYDE; PROTEIN TYROSINE KINASE; VASCULOTROPIN ANTIBODY;

ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL CONTACT; CELL INTERACTION; CELL STRAIN; DISEASE ASSOCIATION; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; METASTASIS; METASTASIS POTENTIAL; PANCREAS CARCINOMA; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CARCINOMA; CELL ADHESION; ELECTROPHYSIOLOGY; ENDOTHELIAL CELLS; HUMANS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PERMEABILITY; TUMOR CELLS, CULTURED; UMBILICAL VEINS;

EID: 29644445158     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00102.x     Document Type: Article

References (49)

1. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-8.
2. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997; 80: 1529-37.
3. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-72.
4. Nicolson GL. Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol 1989; 1: 1009-19.
5. Orr FW, Wang HH. Tumor cell interactions with the microvasculature: a rate-limiting step in metastasis. Surg Oncol Clin N Am 2001; 10: 357-81, ix-x.
6. Mook OR, Van Marle J, Vreeling-Sindelarova H, Jonges R, Frederiks WM, Van Noorden CJ. Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology 2003; 38: 295-304.
7. Luzzi KJ, MacDonald IC, Schmidt EE et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998; 153: 865-73.
8. Haier J, Korb T, Hotz B, Spiegel HU, Senninger N. An intravital model to monitor steps of metastatic tumor cell adhesion within the hepatic microcirculation. J Gastrointest Surg 2003; 7: 507-14.
9. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000; 6: 100-02.
10. Wong CW, Song C, Grimes MM et al. Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am J Pathol 2002; 161: 749-53.
11. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 2004; 5: 261-70.
12. Lewalle JM, Bajou K, Desreux J et al. Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro. Exp Cell Res 1997; 237: 347-56.
13. Cai J, Jiang WG, Mansel RE. Phosphorylation and disorganization of vascular-endothelial cadherin in interaction between breast cancer and vascular endothelial cells. Int J Mol Med 1999; 4: 191-5.
14. Longo N, Yanez-Mo M, Mittelbrunn M et al. Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells. Blood 2001; 98: 3717-26.
15. Mizejewski GJ. Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 1999; 222: 124-38.
16. St-Pierre Y, Aoudjit F, Lalancette M, Potworowski EF. Dissemination of T cell lymphoma to target organs: a post-homing event implicating ICAM-1 and matrix metalloproteinases. Leuk Lymphoma 1999; 34: 53-61.
17. Holzmann B, Gosslar U, Bittner M. α4 integrins and tumor metastasis. Curr Top Microbiol Immunol 1998; 231: 125-41.
18. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 2004; 95: 377-84.
19. Gunthert U, Hofmann M, Rudy W et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
20. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463-516.
21. Seiki M, Yana I. Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Sci 2003; 94: 569-74.
22. Nakamori S, Okamoto H, Kusama T et al. Increased endothelial cell retraction and tumor cell invasion by soluble factors derived from pancreatic cancer cells. Ann Surg Oncol 1997; 4: 361-8.
23. Honn KV, Tang DG, Grossi I et al. Tumor cell-derived 12 (S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res 1994; 54: 565-74.
24. Honn KV, Grossi IM, Diglio CA, Wojtukiewicz M, Taylor JD. Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12 (S)-HETE-induced endothelial cell retraction. FASEB J 1989; 3: 2285-93.
25. Weis S, Cui J, Barnes L, Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 2004; 167: 223-9.
26. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 1998; 111: 1853-65.
27. Walker DC, MacKenzie A, Hosford S. The structure of the tricellular region of endothelial tight junctions of pulmonary capillaries analyzed by freeze-fracture. Microvasc Res 1994; 48: 259-81.
28. Burns AR, Walker DC, Smith CW. Relationship between tight junctions and leukocyte transmigration. In: Cereijido M, Anderson J, eds. Tight Junctions, 2nd edn. Florido: CRC Press, 2001; 629-52.
29. Dejana E, Corada M, Lampugnani MG. Endothelial cell-to-cell junctions. FASEB J 1995; 9: 910-8.
30. Dejana E, Del Maschio A. Molecular organization and functional regulation of cell to cell junctions in the endothelium. Thromb Haemost 1995; 74: 309-12.
31. Burns AR, Walker DC, Brown ES et al. Neutrophil transendothelial migration is independent of tight junctions and occurs preferentially at tricellular comers. J Immunol 1997; 159: 2893-903.
32. Burns AR, Smith CW, Walker DC. Unique structural features that influence neutrophil emigration into the lung. Physiol Rev 2003; 83: 309-36.
33. Burns AR, Bowden RA, MacDonell SD et al. Analysis of tight junctions during neutrophil transendothelial migration. J Cell Sci 2000; 113: 45-57.
34. DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999; 117: 1464-84.
35. Hotz HG, Reber HA, Hotz B et al. An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer. Pancreas 2003; 26: e89-98.
36. Schwarz RE, McCarty TM, Peralta EA, Diamond DJ, Ellenhorn JD. An orthotopic in vivo model of human pancreatic cancer. Surgery 1999; 126: 562-7.
37. Gautam N, Hedqvist P, Lindbom L. Kinetics of leukocyte-induced changes in endothelial barrier function. Br J Pharmacol 1998; 125: 1109-14.
38. Wojciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 2001; 114: 1343-55.
39. Morimoto Y, Nishikawa K, Ohashi M. KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α production. Life Sci 1997; 61: 795-803.
40. Wojtowicz-Praga SM, Dickson RB, Hawkins MJ. Matrix metalloproteinase inhibitors. Invest New Drugs 1997; 15: 61-75.
41. Misumi Y, Misumi Y, Miki K, Takatsuki A, Tamura G, Ikehara Y. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J Biol Chem 1986; 261: 11398-403.
42. Itakura J, Ishiwata T, Friess H et al. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res 1997; 3: 1309-16.
43. Goto T, Maeda H, Tanaka T. A selective inhibitor of matrix metalloproteinases inhibits the migration of isolated osteoclasts by increasing the life span of podosomes. J Bone Miner Metab 2002; 20: 98-105.
44. Kajita M, Itoh Y, Chiba T et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001; 153: 893-904.
45. Uehara Y, Fukazawa H. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases. Meth Enzymol 1991; 201: 370-9.
46. Takai Y, Irie K, Shimizu K, Sakisaka T, Ikeda W. Nectins and nectin-like molecules. Roles in cell adhesion, migration, and polarization. Cancer Sci 2003; 94: 655-67.
47. Reymond N, Imbert AM, Devilard E et al. DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med 2004; 199: 1331-41.
48. Schulte J, Tepass U, Auld VJ. Gliotactin, a novel marker of tri-cellular junctions, is necessary for septate junction development in Drosophila. J Cell Biol 2003; 161: 991-1000.
49. Venema DR, Zeev-Ben-Mordehai T, Auld VJ. Transient apical polarization of Gliotactin and Coracle is required for parallel alignment of wing hairs in Drosophila. Dev Biol 2004; 275: 301-14.